LIPOVA Trademark
Serial Number: 79225469 • Registration: 5494786
LIPOVA is a trademark filed by
VAV LIFE SCIENCES PVT LTD
on June 21, 2017. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
VAV LIFE SCIENCES PVT LTD
51/b mittal court,
Nariman point
Mumbai,
INDIA
Trademark Details
Filing Date
June 21, 2017
Registration Date
June 19, 2018
Published for Opposition
April 3, 2018
Cancellation Date
January 3, 2025
Goods & Services
Egg lecithin for medical purposes
Filing History
TOTAL INVALIDATION PROCESSED BY THE IB
Apr 16, 2026 INNT
GENERIC MADRID TRANSACTION SENT TO IB
Feb 21, 2026 XXSS
GENERIC MADRID TRANSACTION CREATED
Feb 21, 2026 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 10, 2025 INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 3, 2025 INTR
CANCELLED SECTION 71
Jan 3, 2025 C71T
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 12, 2018 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Sep 22, 2018 FICS
FINAL DISPOSITION PROCESSED
Sep 22, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 19, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 19, 2018 R.PR
PUBLISHED FOR OPPOSITION
Apr 3, 2018 PUBO
NOTICE OF PUBLICATION
Mar 14, 2018 NPUB
REFUSAL PROCESSED BY IB
Mar 2, 2018 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 27, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 20, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 20, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 20, 2018 TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 20, 2018 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 9, 2018 RFCS
REFUSAL PROCESSED BY MPU
Feb 9, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 7, 2018 RFCR
NON-FINAL ACTION WRITTEN
Feb 6, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
Feb 2, 2018 MAFR
ASSIGNED TO EXAMINER
Jan 29, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 29, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 25, 2018 REPR
